Skip to main content
Log in

Triple-Therapien und weitere Kombinationen

Fernmetastasiertes Melanom: neue Therapiestudien

  • Fortbildung
  • Fernmetastasiertes Melanom
  • Published:
hautnah dermatologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ribas A et al. Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma. Nat Med. 2019; 25: 936-40

    Article  CAS  Google Scholar 

  2. Sullivan RJ et al. Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. Nat Med. 2019; 25: 929-35

    Article  CAS  Google Scholar 

  3. Ascierto PA et al. Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. Nat Med. 2019; 25: 941-946

    Article  CAS  Google Scholar 

  4. Long GV et al. The anti-PD-1 antibody spartalizumab in combination with dabrafenib and trametinib in previously untreated patients with advanced BRAF V600-mutant melanoma: updated efficacy and safety from parts 1 and 2 of MBI-i. J Clin Oncol. 2019; 37 (Suppl): Abstr 9531

  5. Hurwitz M et al. Baseline tumor immune signatures associated with response to bempegaldesleukin (NKTR-214) and nivolumab. J Clin Oncol. 2019; 37 (Suppl): Abstr 2623

    Article  Google Scholar 

  6. Long GV et al. Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/ KEYNOTE-252 study. J Clin Oncol. 2018; 36 (Suppl): Abstr 108

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Axel Hauschild.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hauschild, A. Fernmetastasiertes Melanom: neue Therapiestudien. hautnah dermatologie 36 (Suppl 1), 19–23 (2020). https://doi.org/10.1007/s15012-019-0001-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-019-0001-z

Navigation